Regulus Therapeutics (RGLS) Insider Trading & Ownership $1.31 +0.04 (+3.15%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.34 +0.02 (+1.91%) As of 02/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Regulus Therapeutics (NASDAQ:RGLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.35%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$82,566.60Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$282,237.48 Get RGLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Regulus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RGLS Insider Buying and Selling by Quarter Regulus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/30/2025David BaltimoreDirectorBuy19,610$1.06$20,786.60 1/30/2025Joseph P HaganCEOBuy50,000$1.09$54,500.00 1/13/2025Christopher Ray AkerVPSell38,547$1.26$48,569.22 1/13/2025Crispina CalsadaCFOSell38,716$1.26$48,782.16 1/13/2025Joseph P HaganCEOSell115,290$1.26$145,265.40 1/13/2025Preston KlassenInsiderSell31,445$1.26$39,620.70 7/25/2024Kathryn J CollierDirectorBuy4,000$1.82$7,280.00 (Data available from 1/1/2013 forward) RGLS Insider Trading Activity - Frequently Asked Questions Who is on Regulus Therapeutics's Insider Roster? The list of insiders at Regulus Therapeutics includes Christopher Ray Aker, Crispina Calsada, David Baltimore, Joseph P Hagan, Kathryn J Collier, and Preston Klassen. Learn more on insiders at RGLS. What percentage of Regulus Therapeutics stock is owned by insiders? 4.35% of Regulus Therapeutics stock is owned by insiders. Learn more on RGLS's insider holdings. Which Regulus Therapeutics insiders have been buying company stock? The following insiders have purchased RGLS shares in the last 24 months: David Baltimore ($20,786.60), Joseph P Hagan ($54,500.00), and Kathryn J Collier ($7,280.00). How much insider buying is happening at Regulus Therapeutics? Insiders have purchased a total of 73,610 RGLS shares in the last 24 months for a total of $82,566.60 bought. Which Regulus Therapeutics insiders have been selling company stock? The following insiders have sold RGLS shares in the last 24 months: Christopher Ray Aker ($48,569.22), Crispina Calsada ($55,289.08), Joseph P Hagan ($162,615.60), and Preston Klassen ($39,620.70). How much insider selling is happening at Regulus Therapeutics? Insiders have sold a total of 244,046 Regulus Therapeutics shares in the last 24 months for a total of $306,094.60 sold. Regulus Therapeutics Key ExecutivesMr. Joseph P. Hagan M.B.A. (Age 55)CEO & Director Compensation: $958.23k2 recent tradesMs. Crispina Calsada CPA (Age 54)Chief Financial Officer Compensation: $579.3k1 recent tradesMr. Christopher Ray Aker J.D. (Age 63)Senior VP, General Counsel & Corporate Secretary Compensation: $575.94k1 recent tradesDr. Preston S. Klassen M.D. (Age 55)M.H.S., President, Head of Research & Development and Director Mr. Daniel J. Penksa (Age 38)VP of Finance & Controller Dr. Claire Susan Padgett M.S.M.T., Ph.D., Senior Vice President of Clinical OperationsDr. Rekha Garg M.D.M.S., Senior Vice President of Clinical Development & RegulatoryMr. Edmund Lee Ph.D.Vice President of Translational Medicine More Insider Trading Tools from MarketBeat Related Companies XOMA Insider Trades Ironwood Pharmaceuticals Insider Trades Verastem Insider Trades Vanda Pharmaceuticals Insider Trades Sangamo Therapeutics Insider Trades Lexicon Pharmaceuticals Insider Trades Achieve Life Sciences Insider Trades Agenus Insider Trades Dominari Insider Trades Fortress Biotech Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:RGLS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regulus Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regulus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
